272 related articles for article (PubMed ID: 2422013)
1. Antagonism to estradiol in the mouse: reduced entry of receptors complexed with 4-hydroxytamoxifen into a Mg2+-soluble chromatin fraction.
Pavlik EJ; van Nagell JR; Nelson K; Gallion H; Donaldson ES; Kenady DE; Baranowska-Kortylewicz J
Endocrinology; 1986 May; 118(5):1924-34. PubMed ID: 2422013
[TBL] [Abstract][Full Text] [Related]
2. Extensive in situ activation of nuclear estrogen receptors after exposure of murine uteri to [3H]estradiol or [3H]4-hydroxytamoxifen.
Pavlik EJ; Nelson K; van Nagell JR; Donaldson ES; Walden ML; Gallion H; Kenady DE
Endocrinology; 1987 Apr; 120(4):1608-14. PubMed ID: 3830064
[TBL] [Abstract][Full Text] [Related]
3. Hydrodynamic characterizations of estrogen receptors complexed with [3H]-4-hydroxytamoxifen: evidence in support of contrasting receptor transitions mediated by different ligands.
Pavlik EJ; Nelson K; van Nagell JR; Donaldson ES; Walden ML; Hanson MB; Gallion H; Flanigan RC; Kenady DE
Biochemistry; 1985 Dec; 24(27):8101-6. PubMed ID: 4092059
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the physicochemical properties of uterine nuclear estrogen receptors bound to estradiol or 4-hydroxytamoxifen.
Attardi B; Happe HK
Endocrinology; 1986 Aug; 119(2):904-15. PubMed ID: 3732150
[TBL] [Abstract][Full Text] [Related]
5. Modulation of rat uterine steroid hormone receptors by estrogen and antiestrogen.
Dix CJ; Jordan VC
Endocrinology; 1980 Dec; 107(6):2011-20. PubMed ID: 7191796
[TBL] [Abstract][Full Text] [Related]
6. Bioactivities, estrogen receptor interactions, and plasminogen activator-inducing activities of tamoxifen and hydroxy-tamoxifen isomers in MCF-7 human breast cancer cells.
Katzenellenbogen BS; Norman MJ; Eckert RL; Peltz SW; Mangel WF
Cancer Res; 1984 Jan; 44(1):112-9. PubMed ID: 6537799
[TBL] [Abstract][Full Text] [Related]
7. Acceptor sites on chromatin for receptor bound by estrogen versus antiestrogen in antiestrogen-sensitive and -resistant MCF-7 cells.
Singh RK; Ruh MF; Butler WB; Ruh TS
Endocrinology; 1986 Mar; 118(3):1087-95. PubMed ID: 3948766
[TBL] [Abstract][Full Text] [Related]
8. Antiestrogen binding in antiestrogen growth-resistant estrogen-responsive clonal variants of MCF-7 human breast cancer cells.
Miller MA; Lippman ME; Katzenellenbogen BS
Cancer Res; 1984 Nov; 44(11):5038-45. PubMed ID: 6488162
[TBL] [Abstract][Full Text] [Related]
9. Dose-dependent effects of 4-hydroxytamoxifen, the active metabolite of tamoxifen, on estrogen receptor-alpha expression in the rat uterus.
Reed CA; Berndtson AK; Nephew KP
Anticancer Drugs; 2005 Jun; 16(5):559-67. PubMed ID: 15846122
[TBL] [Abstract][Full Text] [Related]
10. Activation of [3H]estradiol--and [3H]H1285-receptor complexes: effect of salt versus ATP on molybdate-stabilized estrogen receptors.
Singh RK; Ruh MF; Ruh TS
J Steroid Biochem; 1984 Aug; 21(2):205-8. PubMed ID: 6482431
[TBL] [Abstract][Full Text] [Related]
11. Interaction of the antiestrogen [3H]H1285 with the two forms of the molybdate-stabilized calf uterine estrogen receptor.
Keene JL; Ruh MF; Ruh TS
J Steroid Biochem; 1984 Dec; 21(6):625-31. PubMed ID: 6527530
[TBL] [Abstract][Full Text] [Related]
12. Tissue and species specificity of unmasked nuclear acceptor sites for the estrogen receptor of Squalus testes.
Ruh MF; Singh RK; Mak P; Callard GV
Endocrinology; 1986 Feb; 118(2):811-8. PubMed ID: 3943492
[TBL] [Abstract][Full Text] [Related]
13. Resistance to tamoxifen with persisting sensitivity to estrogen: possible mediation by excessive antiestrogen binding site activity.
Pavlik EJ; Nelson K; Srinivasan S; Powell DE; Kenady DE; DePriest PD; Gallion HH; van Nagell JR
Cancer Res; 1992 Aug; 52(15):4106-12. PubMed ID: 1638522
[TBL] [Abstract][Full Text] [Related]
14. 4-Hydroxytamoxifen inhibits K(+) currents in mouse ventricular myocytes.
El Gebeily G; Fiset C
Eur J Pharmacol; 2010 Mar; 629(1-3):96-103. PubMed ID: 20006599
[TBL] [Abstract][Full Text] [Related]
15. Effect of antibodies to estrogen receptor on the binding of 3H-labeled antiestrogens and androstanediol in the uterus.
Garcia M; Greene G; Rochefort H; Jensen EV
Endocrinology; 1982 Apr; 110(4):1355-61. PubMed ID: 7060530
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of the estrogen receptor interaction with 4-hydroxytamoxifen.
Sasson S; Notides AC
Mol Endocrinol; 1988 Apr; 2(4):307-12. PubMed ID: 3380103
[TBL] [Abstract][Full Text] [Related]
17. Estrogen-receptor--DNA interaction. Difference between activation by estrogen and antiestrogen.
Evans E; Baskevitch PP; Rochefort H
Eur J Biochem; 1982 Nov; 128(1):185-91. PubMed ID: 7173202
[TBL] [Abstract][Full Text] [Related]
18. Effects of sulfhydryl reagents on uterine nuclear estrogen receptors labeled by in vitro exchange with [3H]estradiol or [3H]4-hydroxytamoxifen.
Attardi B
J Recept Res; 1984; 4(7):787-800. PubMed ID: 6527361
[TBL] [Abstract][Full Text] [Related]
19. Immunological differences between the estradiol-, tamoxifen- and 4-hydroxy-tamoxifen-estrogen receptor complexes detected by two monoclonal antibodies.
Giambiagi N; Pasqualini JR
J Steroid Biochem; 1988; 30(1-6):213-7. PubMed ID: 3386244
[TBL] [Abstract][Full Text] [Related]
20. Interaction of estradiol and estriol with uterine estrogen receptor in vivo and in excised uteri or cell suspensions at 37 C: noncooperative estradiol binding and absence of estriol inhibition of estradiol-induced receptor activation and transformation.
Müller RE; Traish AM; Wotiz HH
Endocrinology; 1985 Nov; 117(5):1839-47. PubMed ID: 4042965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
